Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-07-13 Purchase |
2023-07-17 8:00 pm |
Apogee Therapeutics Inc. | APGE | Shah Nimish P Director |
1,750,000 | $17 | $29,750,000 | 1,797,758 (Indirect Direct) |
View |
| 2023-07-13 Purchase |
2023-07-17 8:00 pm |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director |
2,941,176 | $17 | $49,999,992 | 988,045 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-17 Option Award |
2023-08-21 4:06 pm |
N/A 2033-08-17 |
Apogee Therapeutics Inc. | APGE | McKenna Mark C. Director |
150,000 | $0 | 200,000 (Direct) |
View |
| 2023-07-13 Option Award |
2023-07-17 8:01 pm |
N/A 2033-07-13 |
Apogee Therapeutics Inc. | APGE | Gottesdiener Andrew Director |
47,758 | $0 | 47,758 (Direct) |
View |
| 2023-07-13 Option Award |
2023-07-17 8:00 pm |
N/A 2033-07-13 |
Apogee Therapeutics Inc. | APGE | Shah Nimish P Director |
47,758 | $0 | 1,797,758 (Direct) |
View |
| 2023-07-13 Option Award |
2023-07-17 8:00 pm |
N/A 2033-07-13 |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director |
95,516 | $0 | 988,045 (Direct) |
View |
Ownership(A) |
2023-07-17 5:06 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
0 | $0 | 300,788 (Direct) |
View |
Ownership(A) |
2023-07-17 5:05 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer |
0 | $0 | 206,871 (Direct) |
View |
Ownership(A) |
2023-07-17 5:04 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer |
0 | $0 | 1,489,487 (Direct) |
View |
Ownership(A) |
2023-07-17 5:03 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Fox Jennifer A. Director |
0 | $0 | 34,824 (Direct) |
View |
Ownership(A) |
2023-07-17 4:59 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | JONES WILLIAM A JR Director |
0 | $0 | 34,824 (Direct) |
View |
Ownership |
2023-07-13 6:42 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
0 | $0 | 279,105 (Direct) |
View |
Ownership |
2023-07-13 6:42 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer |
0 | $0 | 188,286 (Direct) |
View |
Ownership |
2023-07-13 6:42 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer |
0 | $0 | 1,404,304 (Direct) |
View |
Ownership |
2023-07-13 6:41 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Fox Jennifer A. Director |
0 | $0 | 30,187 (Direct) |
View |
Ownership |
2023-07-13 6:40 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | JONES WILLIAM A JR Director |
0 | $0 | 30,187 (Direct) |
View |
Ownership |
2023-07-13 6:39 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Shah Nimish P Director |
0 | $0 | 6,743,321 (Indirect) |
View |
Ownership |
2023-07-13 6:39 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director |
0 | $0 | 6,743,321 (Indirect) |
View |